Conflicts of Interest: More Questions than Answers
It was fitting that this year's TCT conference included a session on physician/industry conflicts of interest since this has been a hot topic recently in the press, and because TCT is probably the most industry-focused of all the major clinical conferences. Not surprisingly, the panel of physicians raised more questions than answers about both individual and institutional conflicts and how they should be handled.
You may also be interested in...
Over the past several years, increased public scrutiny, from both Federal agencies and the general media, have focused on the close collaborations between product companies and the physicians who help them develop and test new products, alleging that some relationships are too close leading to physicians who put personal financial gain ahead of patient care. Though it was recently cleared by the Department of Justice in a high profile whistle blower case, few companies have found themselves as closely watched as spine leader Medtronic Sofamor Danek.
EU marketing authorization applications for 12 products, including Skycovion, trastuzumab duocarmazine, alpelisib and sparsenta, are now being evaluated by the European Medicines Agency.
The COVID-19 pandemic has underlined the need for less well-resourced countries to improve access to medicines, vaccines, medical devices and other health products by building their own production capacities.